EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Otto Dapunt
Hans J. Geissler
Uwe Mehlhorn
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuhn-Régnier, F.
Right arrow Articles by Mehlhorn, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuhn-Régnier, F.
Right arrow Articles by Mehlhorn, U.

Eur J Cardiothorac Surg 1999;15:67-74
© 1999 Elsevier Science NL


Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation1

Ferdinand Kuhn-Régniera, Ehsan Natoura, Stefan Dheind, Otto Dapunta, Hans J. Geisslera, Karl LaRoséb, Christoph Görgc, Uwe Mehlhorna

a Department of Cardiothoracic Surgery, University of Cologne; Joseph Stelzmannstr. 9, 50924 Cologne, Germany
b Department of Cardiology, University of Cologne; Joseph Stelzmannstr. 9, 50924 Cologne, Germany
c Department of Anesthesiology, University of Cologne; Joseph Stelzmannstr. 9, 50924 Cologne, Germany
d Department of Pharmacology, University of Cologne; Joseph Stelzmannstr. 9, 50924 Cologne, Germany

Received 22 September 1998; received in revised form 10 November 1998; accepted 25 November 1998.

Corresponding author. Tel.: +49-221-478-6043; fax:+49-221-478-5906; e-mail: ferdinand.kuhn-regnier@medizin.uni-koeln.de

Objective: Continuous perfusion of the coronary arteries with ß-blocker (esmolol)-enriched normothermic blood during cardiac surgery has been suggested as an alternative technique for myocardial protection. The aim of the present study was to compare the ß-blocker technique to Buckberg's blood cardioplegia during coronary artery bypass grafting (CABG). Methods: Sixty patients with coronary artery disease were randomly assigned to either the esmolol group (ES, n=30) or the blood cardioplegia group (BC, n=30). During aortic cross-clamp ES patients received continuous normothermic coronary perfusion with esmolol-enriched blood. Hearts of the BC group were protected by antegrade cold blood cardioplegia according to Buckberg. We measured left ventricular (LV) contractility using TEE (fractional area of contraction, FAC) and hemodynamic parameters prior to cannulation for cardiopulmonary bypass (CPB), after decannulation, and 4 h postoperatively. Myocardial lactate release was measured prior to aortic cross-clamp, during cross-clamp, and after decannulation. LV biopsies for determination of heat-shock protein (HSP-70), actin pattern and intercellular adhesion-molecule (ICAM-I) as indicators for structural changes were collected prior CPB, at the end of the aortic cross-clamp period, and prior to weaning off CPB. Results: There was no significant difference between both groups with respect to grafts and cross-clamp time. ES hearts did not release lactate during cross-clamp. In contrast, BC hearts released significant amounts of lactate. Post CPB FAC and hemodynamics under similar inotropic stimulation showed no difference between groups, whereas at 4 h post CPB measurements showed slightly better values in the ES group: cardiac index: ES: 2.9±0.1 (SEM) versus BC: 2.6±0.1 L/min per m2 (P<0.05); FAC: ES: 55±3 versus BC: 48±3% (P<0.05). HSP-70 and actin pattern showed no difference between groups; however, ICAM-I showed a significantly higher degree of structural changes in BC hearts: 18±2 versus ES: 11±1% (P<0.05). Conclusion: Our data demonstrate that application of the ß-blocker technique during routine CABG was associated with slightly better functional recovery and less structural myocardial alteration as compared with intermittent cold blood cardioplegia, however, both techniques provided equivalent myocardial protection in terms of patient outcome. Future studies are required to investigate if myocardial ischemia minimization by use of the ß-blocker technique may be beneficial in compromized hearts.

Key Words: Beta-blocker • Esmolol • Myocardial protection • Blood cardioplegia • Coronary surgery • Intercellular adhesion molecule • Cardiopulmonary bypass




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli
Myocardial protection in adult cardiac surgery: current options and future challenges
Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. J. Chambers
Mechanisms and alternative methods of achieving cardiac arrest
Ann. Thorac. Surg., February 1, 2003; 75(2): S661 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Bessho and D. J. Chambers
Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat
J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 340 - 351.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Mehlhorn, H. J. Geissler, G. A. Laine, and S. J. Allen
Myocardial fluid balance
Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1220 - 1230.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Bessho and D. J. Chambers
Myocardial protection: The efficacy of an ultra-short-acting {beta}-blocker, esmolol, as a cardioplegic agent
J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 993 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Mehlhorn, H. J. Geissler, G. A. Laine, and S. J. Allen
Role of the cardiac lymph system in myocardial fluid balance
Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 424 - 425.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Mehlhorn, W. Bloch, A. Krahwinkel, K. LaRose, H.-J. Geissler, K. Hekmat, K. Addicks, and E. R. de Vivie
Activation of myocardial constitutive nitric oxide synthase during coronary artery surgery
Eur. J. Cardiothorac. Surg., March 1, 2000; 17(3): 305 - 311.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. J. Geissler, K. L. Davis, G. A. Laine, E. J. Ostrin, U. Mehlhorn, K. Hekmat, R. David Warters, and S. J. Allen
Myocardial protection with high-dose {beta}-blockade in acute myocardial ischemia
Eur. J. Cardiothorac. Surg., January 1, 2000; 17(1): 63 - 70.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.